Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Notes Payables (2018 - 2022)

Inspire Medical Systems (INSP) has disclosed Notes Payables for 3 consecutive years, with $12.2 million as the latest value for Q2 2022.

  • Quarterly Notes Payables rose 299.93% to $12.2 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $12.2 million through Jun 2022, up 299.93% year-over-year, with the annual reading at $9.2 million for FY2021, N/A changed from the prior year.
  • Notes Payables hit $12.2 million in Q2 2022 for Inspire Medical Systems, roughly flat from $12.2 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $12.2 million in Q1 2022 to a low of $681000.0 in Q1 2018.
  • Historically, Notes Payables has averaged $6.6 million across 3 years, with a median of $6.1 million in 2021.
  • Biggest YoY gain for Notes Payables was 299.93% in 2022; the steepest drop was 299.93% in 2022.
  • Year by year, Notes Payables stood at $2.7 million in 2018, then skyrocketed by 237.55% to $9.2 million in 2021, then surged by 33.33% to $12.2 million in 2022.
  • Business Quant data shows Notes Payables for INSP at $12.2 million in Q2 2022, $12.2 million in Q1 2022, and $9.2 million in Q4 2021.